Chapter 08

  1. Abdelmagid OY, Larson L, Payne L, et al. 2004. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus and distemper virus experimental challenges. Vet Ther 5:173-186.
  2. Agungpriyono DR, Uchida K, Tabaru H, et al. 1999. Subacute massive necrotizing myocarditis by canine parvovirus type 2 infection with diffuse leukoencephalomalacia in a puppy. Vet Pathol 36:77-80.
  3. American Animal Hospital Association (AAHA) Canine Vaccine Task Force, Paul MA, Carmichael LE, Childers H, et al. 2006. 2006 AAHA canine vaccine guidelines. J Am Anim Hosp Assoc 42:80-89.
  4. Atkinson M. 2006. Canine parvovirus vaccination. Vet Rec 159:895.
  5. Atkinson M. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:428.
  6. Baatz G. 1992. Ten years of clinical experiences with canine parvovirus infection (CPV-2 infection). Tierarztl Prax 20:69-78.
  7. Bandai C, Ishiguro S, Masuya N, et al. 1999. Canine coronavirus infections in Japan: virological and epidemiological aspects. J Vet Med Sci 61:731-736.
  8. Battilani M, Gallina L, Vaccari F, et al. 2007. Co-infection with multiple variants of canine parvovirus type 2 (CPV-2). Vet Res Commun 31(Suppl 1):209-212
  9. Battilani M, Scagliarini A, Tisato E, et al. 2001. Analysis of canine parvovirus sequences from wolves and dogs isolated in Italy. J Gen Virol 82:1555-1560.
  10. Benetka V, Kolodziejek J, Walk K, et al. 2006. M gene analysis of atypical strains of feline and canine coronavirus circulating in an Austrian animal shelter. Vet Rec 159:170-174.
  11. Bergman JGHE, Muniz M, Sutton, D et al. 2006. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec 159:733-736.
  12. Binns SH, Dawson S, Speakman AJ, et al. 2000. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. J Feline Med Surg 2:123-133.
  13. Brunet S, Toulemonde C, Cariou C, et al. 2007. Efficacy of vaccination with a canine parvovirus type 2 against a virulent challenge with a CPV type 2c (GLU426), abstract OC 3. In Proceedings of the International Parvovirus Meeting, Sept 27-28, Bari, Italy.
  14. Buonavoglia C, Decaro N, Martella V, et al. 2006. Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis 12:492-494.
  15. Buonavoglia C, Martella V, Pratelli A, et al. 2001. Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 82:3021-3025.
  16. Buonavoglia C, Tollis M, Buonavoglia D, et al. 1992. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine. Comp Immunol Microbiol Infect Dis 15:281-283.
  17. Burtonboy S, Charlier P, Hertoghs J, et al. 1991. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet Rec 128:377-381.
  18. Calderon MG, Mattion N, Bucafusco D, et al. 2009. Molecular characterization of canine parvovirus strains in Argentina: detection of the pathogenic variant CPV2c in vaccinated dogs. J Virol Methods 159:141-145.
  19. Carmichael LE. 2005. An annotated historical account of canine parvovirus. J Vet Med B 52:303-311.
  20. Carmichael LE, Schlafer DH, Hashimoto A. 1991. Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet 81:151-171.
  21. Carmichael LE, Schlafer DH, Hashimoto A. 1994. Minute virus of canines (MVC, canine parvovirus—type 1):pathogenicity for pups and seroprevalence estimate. J Vet Diagn Invest 6:165-174.
  22. Cavalli A, Martella V, Desario C, et al. 2008. Evaluation of the antigenic relationships among canine parvovirus type 2 variants. Clin Vaccine Immunol 15:534-539.
  23. Cesar ADP, Telma AM, Dolores UM, et al. 2000. Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay. Vet Microbiol 75:127-133.
  24. Chang WL, Chang ACH, Pan MJ. 1996. Antigenic types of canine parvoviruses prevailing in Taiwan. Vet Rec 138:447.
  25. Chinchkar SR, Subramanian BM, Rao NH, et al. 2006. Analysis of VP2 gene sequences of canine parvovirus isolates in India. L. E. Arch Virol 151:1881-1887.
  26. Cho H-S, Kang J-I, Park N-Y. 2006. Detection of canine parvovirus in fecal samples using loop-mediated isothermal amplification. J Vet Diagn Invest 18:81-84.
  27. Cohn LA, Rewerts JM, McCaw D, et al. 1999. Plasma granulocyte colony-stimulating factor concentrations in neutropenic, parvoviral enteritis-infected puppies. J Vet Intern Med 13:581-586.
  28. Corrain R, Di Francesco A, Bolognini M, et al. 2007. Serosurvey for CPV-2, distemper virus, ehrlichiosis and leishmaniosis in free-ranging dogs in Italy. Vet Rec 160:91-92.
  29. Costa AP, Leite JPG, Labarthe, NV, et al. 2005. Genomic typing of canine parvovirus circulating in the State of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay. Vet Res Commun 29:735-743.
  30. Courtenay O, Quinnell RJ, Chalmers WSK. 2001. Contact rates between wild and domestic canids: no evidence of parvovirus or canine distemper virus in crab-eating foxes. Vet Microbiol 81:9-19.
  31. Coyne MJ. 2000. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies. Vet Ther 1:35-42.
  32. Crandell RA. 1988. Isolation and characterization of caliciviruses from dogs with vesicular genital diseases. Arch Virol 98:65-71.
  33. Davies M. 2008. Canine parvovirus strains identified from clinically ill dogs in the United Kingdom. Vet Rec 163:543-544.
  34. de Groot RJ, Ziebuhr J, Poon LL, et al. 2008. Revision of the family Coronaviridae. Taxonomic proposal of the Coronavirus Study Group to the ICTV Executive Committee. http://talk.ictvonline.org/media/p/1230.aspx. Accessed 5/11/11.
  35. Decaro N. 2010. Unpublished data. University of Bari, Bari, Italy.
  36. Decaro N, Altamura M, Pratelli A, et al. 2002. Evaluation of the innate immune response in pups during canine parvovirus type 1 infection. New Microbiol 25:291-298.
  37. Decaro N, Buonavoglia C. 2008. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol 132:221-234.
  38. Decaro N, Buonavoglia C. 2010. Personal communication. University of Bari, Bari, Italy.
  39. Decaro N, Camero M, Greco G, et al. 2004. Canine distemper and related diseases: report of a severe outbreak in a kennel. New Microbiol 27:177-181.
  40. Decaro N, Campolo M, Desario C, et al. 2005. Maternally-derived antibodies in pups and protection from canine parvovirus infection. Biologicals 33:261-267.
  41. Decaro N, Campolo M, Desario C, et al. 2005. Virological and molecular characterization of a mammalian orthoreovirus type 3 strain isolated from a dog in Italy. Vet Microbiol 109:19-27.
  42. Decaro N, Campolo M, Elia G, et al. 2007. Infectious canine hepatitis: an “old” disease reemerging in Italy. Res Vet Sci 83:269-273.
  43. Decaro N, Campolo M, Lorusso A, et al. 2008. Experimental infection of dogs with a novel strain of canine coronavirus causing systemic disease and lymphopenia. Vet Microbiol 128:253-260.
  44. Decaro N, Cirone F, Desario C, et al. 2009. Severe parvovirosis in a repeatedly vaccinated 12-year-old dog. Vet Rec 164:593-595.
  45. Decaro N, Desario C, Addie AD, et al. 2007. Molecular epidemiology of canine parvovirus, Europe. Emerg Infect Dis 13:1222-1224.
  46. Decaro N, Desario C, Beall MJ, et al. 2010. Detection of canine parvovirus type 2c by a commercially available in-house rapid test. Vet J 184:373-375.
  47. Decaro N, Desario C, Billi M, et al. In press. Western European epidemiological survey for parvovirus and coronavirus infections in dogs. Vet J, doi:10.1016/j.tvjl.2009.10.027.
  48. Decaro N, Desario C, Campolo M, et al. 2005. Clinical and virological findings in pups naturally infected by canine parvovirus type 2 Glu-426 mutant. J Vet Diagn Invest 17:133-138.
  49. Decaro N, Desario C, Elia G, et al. 2007. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma. Vaccine 25:1161-1166.
  50. Decaro N, Desario C, Elia G, et al. 2008. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol 31:125-130.
  51. Decaro N, Elia G, Desario C, et al. 2006. A minor groove binder probe real-time PCR assay for discrimination between type 2-based vaccines and field strains of canine parvovirus. J Virol Methods 136:65-70.
  52. Decaro N, Elia G, Martella V, et al. 2005. A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 in the feces of dogs. Vet Microbiol 105:19-28.
  53. Decaro N, Elia G, Martella V, et al. 2006. Characterisation of the canine parvovirus type 2 variants using minor groove binder probe technology. J Virol Methods 133:92-99.
  54. Decaro N, Elia G, Martella V, et al. 2010. Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain. Vaccine 28:724-729.
  55. Decaro N, Mari V, Campolo M, et al. 2009. Recombinant canine coronaviruses related to transmissible gastroenteritis virus of swine are circulating in dogs. J Virol 83:1532-1537.
  56. Decaro N, Mari V, Elia G, et al. 2010. Recombinant canine coronaviruses in dogs, Europe. Emerg Infect Dis 16:41-47.
  57. Decaro N, Martella V, Desario C, et al. 2006. First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J Vet Med B 53:468-472.
  58. Decaro N, Martella V, Elia G, et al. 2006. Diagnostic tools based on minor groove binder probe technology for rapid identification of vaccinal and field strains of canine parvovirus type 2b. J Virol Methods 138:10-16.
  59. Decaro N, Martella V, Elia G, et al. 2007. Molecular characterization of the virulent canine coronavirus CB/05 strain. Virus Res 125;54-60.
  60. Decaro N, Martella V, Elia G, et al. 2007. Tissue distribution of the antigenic variants of canine parvovirus type 2 in dogs. Vet Microbiol 121:39-44.
  61. Decaro N, Martella V, Ricci D, et al. 2005. Genotype-specific fluorogenic RT-PCR assays for the detection and quantitation of canine coronavirus type I and type II RNA in faecal samples of dogs. J Virol Methods 130:72-78.
  62. Decaro N, Pratelli A, Campolo M, et al. 2004. Quantitation of canine coronavirus RNA in the faeces of dogs by TaqMan RT-PCR. J Virol Methods 119:145-150.
  63. Decaro N, Pratelli A, Tinelli A, et al. 2004. Fecal immunoglobulin A antibodies in dogs infected or vaccinated with canine coronavirus. Clin Diagn Lab Immunol 11:102-105.
  64. de Castro TX, Uchoa CMA, de Albuquerque MC, et al. 2007. Canine parvovirus (CPV) and intestinal parasites: laboratorial diagnosis and clinical signs from puppies with gastroenteritis. Intern J Appl Res Vet Med 5:72-76.
  65. De Grazia S, Martella V, Giammanco GM, et al. 2007. Canine-origin G3P[3] rotavirus strain in child with acute gastroenteritis. Emerg Infect Dis 13:1091-1093.
  66. DeMari K, Maynard L, Eun HM, et al. 2003. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 152:105-108.
  67. Demeter Z, Palade EA, Soós T, et al. 2010. Misleading results of the MboII-based identification of type 2a canine parvovirus strains from Hungary reacting as type 2c strains. Virus Genes 41:37-42.
  68. Denholm KM, Haitjema H, Gwynne BJ, et al. 2001. Concurrent Cryptosporidium and parvovirus infections in a puppy. Aust Vet J 79:98-101.
  69. Desario C, Decaro N, Campolo M, et al. 2005. Canine parvovirus infection: which diagnostic test for virus? J Virol Methods 126:179-185.
  70. de Ybañez RR, Vela C, Cortés E, et al. 1995. Identification of types of canine parvovirus circulating in Spain. Vet Rec 136:174-175.
  71. Di Marino B, Di Rocco C, Ceci C, et al. 2009. Characterization of a strain of feline calicivirus isolated from a dog faecal sample. Vet Microbiol 139:52-57.
  72. Dimmit R. 1991. Clinical experience with cross-protective antiendotoxin antiserum in dogs with parvoviral enteritis. Canine Pract 16:23.
  73. Diquelou A, Ragetly G, Laborde M, et al. 2005. Cardiac troponin 1 in normal dogs, dogs suffering trauma or parvovirus infections, Oral platform presentation 25. European Society of Veterinary Clinical Pathology (ESVCP) 7th Annual Meeting In conjunction with the Association of European Comparative Clinical Pathology (AECCP) and the European College of Veterinary Clinical Pathology (ECVCP) 2nd Joint Meeting, June 21-24, Utrecht, The Netherlands.
  74. 73a. Duffy A, Dow S, Ogilvie G, et al. 2010. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor. J Vet Pharmacol Therap 33:352-356.
  75. Dyer F, Spagnuolo-Weaver M. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:605.
  76. East ML, Moestl K, Benetka V, et al. 2004. Coronavirus infection of spotted hyenas in the Serengeti ecosystem. Vet Microbiol 102:1-9.
  77. Elia G, Cavalli A, Desario C, et al. 2007. Detection of infectious canine parvovirus type 2 by mRNA real-time RT-PCR. J Virol Methods 146:202-208.
  78. England GCW, Allen WE. 1991. The lack of effect of parvovirus vaccination on the seminal characteristics of dogs. Vet Rec 128:611-612.
  79. Erles K, Brownlie J. 2009. Sequence analysis of divergent canine coronavirus strains present in a UK dog population. Virus Res 141:21-25.
  80. Escutenaire S, Isaksson M, Renström LH, et al. 2007. Characterization of divergent and atypical canine coronaviruses from Sweden. Arch Virol 152:1507-1514.
  81. Evermann JF, Abbott JR, Han S. 2005. Canine coronavirus associated puppy mortality without evidence of concurrent canine parvovirus infection. J Vet Diagn Invest 17:610-614.
  82. Favrot C, Olivry T, Dunston SM, et al. 2000. Parvovirus infection of keratinocytes as a cause of canine erythema multiforme. Vet Pathol 37:647-649.
  83. Gao FS, Hu GX, Xia XZ, et al. 2009. Isolation and identification of a canine coronavirus strain from giant pandas (Ailuropoda melanoleuca). J Vet Sci 10:261-263.
  84. Finlaison DS. 1995. Faecal viruses of dogs-an electron microscope study. Vet Microbiol 46:295-305.
  85. Fox LM, Bruederle JB. 1996. (Nearly) foolproof parvovirus treatments. Vet Forum Apr:36-38.
  86. Fulker R, Wasmoen T, Atchison R, et al. 1995. Efficacy of an inactivated vaccine against clinical disease caused by canine coronavirus, pp 229-234. In Talbot PJ, Levy GA (eds): Corona- and related viruses. Plenum Press, New York.
  87. Gabriel SS, Toya Y, Mochizuki M. 1996. Isolation of a calicivirus antigenically related to feline caliciviruses from feces of a dog with diarrhea. J Vet Med Sci 58:1031-1043.
  88. Gamoh K, Senda M, Shimazaki Y, et al. 2003. Chronological antigenic survey of canine parvovirus in Japan. Vet Rec 152:142-143.
  89. Gentsch JR, Glass RI, Woods P, et al. 1992. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365-1373.
  90. Gill M, Srinivas J, Morozov I, et al. 2004. Three-year duration of immunity for canine distemper, adenovirus, and parvovirus after vaccination with a multivalent canine vaccine. Int J Appl Res Vet Med 2:227-234.
  91. Glickman LT, Domanski LM, Patronek GJ, et al. 1985. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 187:589-594.
  92. 90a. Goddard A, Leisewitz AL. 2010. Canine parvovirus. Vet Clin Small Anim 40:1041-1053.
  93. Goddard A, Leisewitz AL, Duncan N, et al. 2006. Study of the prognostic usefulness of blood leukocyte changes in canine parvoviral enteritis, European Society of Veterinary Clinical Pathology (ESVCP) Special Program. In conjunction with the European College of Veterinary Internal Medicine-Companion Animals (ECVIM-CA) 16th Congress, Sept 14-16, Amsterdam, The Netherlands. Vet Clin Pathol 35:490.
  94. 91a. Godsall SA, Clegg SR, Stavisky JH, et al. 2010. Epidemiology of canine parvovirus and coronavirus in dogs presented with severe diarrhea to PDSA PetAid hospitals. Vet Rec 167: 196-201.
  95. Gomoh K, Shimazaki Y, Senda M, et al. 2003. Antigenic type distribution of parvovirus isolated from domestic cats in Japan. Vet Rec 153:751-752.
  96. Gore TC, Lakshmanan N, Duncan KL, et al. 2005. Three year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper. Vet Ther 6: 5-14.
  97. Gouvea V, Santos, N, Timenetsky, Mdo C. 1994. Identification of bovine and porcine rotavirus G types by PCR. J Clin Microbiol 32:1338-1340.
  98. Greenwood NM, Chalmers WSK, Baxendale W, et al. 1995. Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains. Vet Rec 136:63-67.
  99. Greenwood NM, Chalmers WSK, Baxendale W, et al. 1996. Comparison of isolates of canine parvovirus by monoclonal antibody and restriction enzyme analysis. Vet Rec 138:495-496.
  100. Hafenstein S, Palermo LM, Kostyuchenko VA, et al. 2007. Asymmetric binding of transferrin receptor to parvovirus capsids. Proc Natl Acad Sci USA 104:6585-6589.
  101. Ham C, Maes R, Vilnis A, et al. 1996. An RT-PCR assay to detect canine coronavirus and porcine transmissible gastroenteritis infections, p 60. In Proceedings of the American Association of Veterinarian Laboratory Diagnoses. Little Rock, AR.
  102. Hamilton RC, Drane DP, Smith HV. 1995. Shedding of "virus-like" particles in canine feces. Vet Microbiol 46:307-313.
  103. Hashimotoa A, Takiguchi M, Hirai K, et al. 2001. A serological survey of minute virus of canines (MVC; canine parvovirus type-1) in dogs in the Tokai area of Japan. Jpn J Vet Res 49:249-253.
  104. Harrington DP, McCaw DL, Jones BD. 1996. A retrospective study of canine parvovirus gastroenteritis: 89 cases. J Am Coll Vet Intern Med 10:157.
  105. Harrison LR, Styer EL, Pursell AR, et al. 1992. Fatal disease in nursing puppies associated with minute virus of canines. J Vet Diagn Invest 4:19-22.
  106. Henry CJ, McCaw DL, Brock KV, et al. 2001. Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs. J Am Vet Med Assoc 219:1238-1241.
  107. Hirayama K, Kano R, Hosokawa-Kanai T, et al. 2005. VP2 gene of a canine parvovirus isolate from stool of puppy. J Vet Med Sci 67:139-143.
  108. Hoelzer K, Shackelton LA, Holmes EC, et al. 2008. Within-host genetic diversity of endemic and emerging parvoviruses of dogs and cats. J Virol 82:11096-11105.
  109. Hong C, Decaro N, Desario C, et al. 2007. Occurrence of canine parvovirus type 2c in the United States. J Vet Diagn Invest 19:535-539.
  110. Hoskins J, Ford RB, Bumbarger J, et al. 2000. Canine parvovirus enteritis. Canine Pract 25:6-10.
  111. Hoskins JD. 1997. Update on canine parvoviral enteritis. Vet Med 92:694-709.
  112. Hoskins JD. 1998. Canine viral enteritis, pp 40-49. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  113. Hoskins JD, Gourley KR, Taylor HW, et al. 1995. Challenge trial of Progard-7 vaccine using three field strains of CPV-2. Intervet's Companion Anim Tech Rep 4:1-4.
  114. Hoskins JD, Mirza T, Taylor HW. 1996. Evaluation of a fecal antigen ELISA test for the diagnosis of canine parvovirus. J Am Coll Vet Intern Med 10:159.
  115. Houston DM, Ribble CS, Head LL. 1996. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982–1991). J Am Vet Med Assoc 208:542-546.
  116. Hueffer K, Govindasamy L, Agbandje-McKenna M, et al. 2003. Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. J Virol 77:10099-10105.
  117. Hueffer K, Parrish CR. 2003. Parvovirus host range, cell tropism and evolution. Curr Opin Microbiol 6:392-398.
  118. Hullinger GA, Hines ME II, Styler EL, et al. 1998. Pseudocytoplasmic inclusions in tongue epithelium of dogs with canine parvovirus-2 infections. J Vet Diagn Invest 10:108-111.
  119. Ikeda Y, Mochizuki M, Naito R, et al. 2000. Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPV's in cats. Virology 278:13-19.
  120. Ikeda Y, Nakamura K, Miyazawa T, et al. 2002. Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. Emerg Infect Dis 8:341-346.
  121. Ilott M. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:722-723.
  122. Ishiwata K, Minagawa T, Kajimoto T. 1998. Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in beagle dogs. J Vet Med Sci 60:911-917.
  123. Jang HK, Toya Y, Han KY, et al. 2003. Seroprevalence of canine calicivirus and canine minute virus in the Republic of Korea. Vet Rec 153:150-152.
  124. Jarplid B, Johansson H, Carmichael LE. 1996. A fatal case of pup infection with minute virus of canines (MVL). J Vet Diagn Invest 8:484-487.
  125. Jeoung SY, Ahn SJ, Kim D. 2008. Genetic analysis of VP2 gene of canine parvovirus isolates in Korea. J Vet Med Sci 70:719-722.
  126. Jiang W, Baker HJ, Swango LJ, et al. 1998. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine 16:601-607.
  127. Jones M. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:605.
  128. Kahn DE, Emery JB, Smith MJ, et al. 1983. Safety and efficacy of modified-live canine parvovirus vaccine. VM/SAC 78:1739-1746.
  129. 125a. Kalli I, Leontides LS, Mylonakis ME, et al. 2010. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res Vet Sci 89:174-178.
  130. Kaneshima T, Hohdatsu T, Hagino R, et al. 2007. The infectivity and pathogenicity of a group 2 bovine coronavirus in pups. J Vet Med Sci 69:301-303.
  131. Kang BK, Song DS, Jung KI, et al. 2007. Genetic characterization of canine rotavirus isolated from a puppy in Korea and experimental reproduction of disease. J Vet Diagn Invest 19:78-83.
  132. Kang BK, Song DS, Lee CS, et al. 2008. Prevalence and genetic characterization of canine parvoviruses in Korea. Virus Genes 36:127-133.
  133. Kapil S, Cooper E, Lamm C, et al. 2007. Canine parvovirus Types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol 45:4044-4047.
  134. Kapil S, Rezabek G, Germany B, et al. 2010. Isolation of a virus related to canine parvovirus type 3 from a raccoon (Procyon lotor). Vet Rec 166:24-25.
  135. Koutinas AF, Heliadis N, Saridomichelakis MN, et al. 1998. Asymptomatic bacteriuria in puppies with canine parvovirus infection: a cohort study. Vet Microbiol 63:109-116.
  136. Kramer JW, Evermann JF, Leathers CW, et al. 1991. Experimental infection of two dogs with a canine isolate of feline herpesvirus type 1. Vet Pathol 28:338-340.
  137. Kuwabara M, Nariai Y, Horiuchi Y, et al. 2006. Immunological effects of recombinant feline interferon-ω (KT-80) administration in the dog. Microbiol Immunol 50: 637-641.
  138. 133a. Kumar M, Nandi S. 2010. Development of as SYBR Green basede real-time PCR assay for detection and quantitation of canine parvovirus in faecal samples. J Virol Meth 169:198-201.
  139. Lacheretz A, Laperrousaz C, Kodjo A, et al. 2003. Diagnosis of canine parvovirus by rapid immunomigration on a membrane. Vet Rec 152:48-50.
  140. Laird AR, Ibarra V, Ruiz-Palacios, et al. 2003. Unexpected detection of animal VP7 genes among common rotavirus strains isolated from children in Mexico. J Clin Microbiol 41:4400-4403.
  141. Lamm CG, Rezabek GB. 2008. Parvovirus infection in domestic companion animals. Vet Clin North Am Small Anim Pract 38:837-850, viii-ix.
  142. Langeveld JPM, Brennan FR, Martínez-Torrecuadrada JL, et al. 2001. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 19:3661-3670.
  143. Larson LJ, Schultz RD. 1996. High-titer canine parvovirus vaccine: serologic response and challenge-of-immunity study. Vet Med 90:210-218.
  144. Larson LJ, Schultz RD. 2008. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet Ther 9:94-101.
  145. Lechner ES, Crawford PC, Edinboro CH, et al. 2009. Prevalence of protective antibody titers for distemper virus and parvovirus in dogs entering a Florida animal shelter. J Vet Intern Med 223:673-786.
  146. Lobetti RG, Joubert KE, Picard J, et al. 2002. Bacterial colonization of intravenous catheters in young dogs suspected to have parvoviral enteritis. J Am Vet Med Assoc 220:1321-1324.
  147. Lorusso A, Decaro N, Schellen P. 2008. Gain, preservation and loss of a group 1a coronavirus accessory glycoprotein. J Virol 82:10312-10317.
  148. Lorusso A, Desario A, Mari V, et al. 2009. Molecular characterization of a canine respiratory coronavirus strain detected in Italy. Virus Res 141:96-100.
  149. Macintire DK. 2001. Intensive care management. In Hoskins JD (ed): Veterinary pediatrics: dogs and cats from birth to six months, ed 3. WB Saunders, Philadelphia.
  150. Macintire DK, Smith-Carr S. 1997. Canine parvovirus infection: clinical signs, diagnosis, and treatment. Compend Contin Educ Pract Vet 19:291-301.
  151. Macintire DK, Smith-Carr S, Jones R, et al. 1999. Treatment of dogs naturally infected with canine parvovirus with lyophilized canine IgG, abstract no. 118. Proceedings of the 17th Annual ACVIM Forum, Jun 10-13, Chicago.
  152. Mann FA, Boon GD, Wagner-Mann CC, et al. 1998. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 212:1398-1401.
  153. Manteufel J, Truyen U. 2008. Animal bocaviruses: a brief review. Intervirology 51:328-334.
  154. Mantione NL, Otto CM. 2005. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000). J Am Vet Med Assoc 227:1787-1793.
  155. Martella V, Cavalli A, Decaro N, et al. 2005. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol 12:1243-1245.
  156. Martella V, Cavalli A, Pratelli A, et al. 2004. A canine parvovirus mutant is spreading in Italy. J Clin Microbiol 42:1333-1336.
  157. 151a. Martella V, Decaro N, Lorusso E, et al. 2009. Genetic heterogeneity and recombination in canine noroviruses. J Virol 83:11391-11396.
  158. Martella V, Lorusso E, Decaro N, et al. 2008. Detection and molecular characterization of a canine norovirus. Emerg Infect Dis 14:1306-1308.
  159. Martella V, Pratelli A, Elia G, et al. 2001. Isolation and genetic characterization of two G3P5A[3] canine rotavirus strains in Italy. J Virol Methods 96:43-49.
  160. Martella V, Pratelli A, Gentile M, et al. 2002. Analysis of the capsid protein gene of a feline-like calicivirus isolated from a dog. Vet Microbiol 85: 315-322.
  161. Martin V, Najbar W, Gueguen S, et al. 2002. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 89:115-127.
  162. Martyn JC, Davidson BE, Studdert MJ. 1990. Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol 71:2747-2753.
  163. Marulappa SY, Kapil S. 2009. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies. Clin Vaccine Immunol 16:127-131.
  164. Matsui T, Matsumoto J, Kanno T, et al. 1993. Intranuclear inclusions in the stratified squamous epithelium in the tongue in dogs and cats with parvovirus infection. Vet Pathol 30:303-305.
  165. Maxson TR, Meurs KM, Lehmkuhl LB, et al. 2001. Polymerase chain reaction analysis for viruses in paraffin-embedded myocardium from dogs with dilated cardiomyopathy or myocarditis. Am J Vet Res 62:130-135.
  166. McCaw DL, Tate D, Dubovi EJ, et al. 1997. Early protection of puppies against canine parvovirus: a comparison of two vaccines. J Am Anim Hosp Assoc 33:244-250.
  167. McCaw DL, Thompson M, Tate D, et al. 1998. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination. J Am Vet Med Assoc 213:72-75.
  168. McKnight CA, Maes RK, Wise AG, et al. 2007. Evaluation of tongue as a complementary sample for the diagnosis of parvoviral infection in dogs and cats. J Vet Diagn Invest 19:409-413.
  169. Mech LD, Goyal SM, Paul WJ, et al. 2008. Demographic effects of canine parvovirus on a free-ranging wolf population over 30 years. J Wildl Dis 44:824-836.
  170. Meers J, Kyaw-Tanner M, Bensink Z, et al. 2007. Genetic analysis of canine parvovirus from dogs in Australia. Aust Vet J 85:392-396.
  171. Minagawa T, Ishiwata K, Kajimoto T. 1999. Feline interferon-ω treatment on canine parvovirus infection. Vet Microbiol 69:51-53.
  172. Mischke R, Barth T, Wohlsein P, et al. 2001. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 70:221-225.
  173. Mochizuki M, Harasawa R, Nakatani H. 1993. Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. Vet Microbiol 38:1-10.
  174. Mochizuki M, Hashimoto M, Hajima T, et al. 2002. Virologic and serologic identification of minute virus of canines (CPV-1) from dogs in Japan. J Clin Microbiol 40:3933-3938.
  175. Mochizuki M, Hashimoto M, Ishida T. 2001. Recent epidemiological status of canine viral enteric infections and Giardia infection in Japan. J Vet Med Sci 63:573-575.
  176. Mochizuki M, Hashimoto M, Roerink F, et al. 2002. Molecular and seroepidemiological evidence of canine calicivirus infections in Japan. J Clin Microbiol 40: 2629-2631.
  177. Mochizuki M, Horiuchi M, Hiragi H, et al. 1996. Isolation of canine parvovirus from a cat manifesting clinical signs of feline panleukopenia. J Clin Microbiol 34:2101-2105.
  178. Mochizuki M, Kawanishi A, Sakamoto H, et al. 1993. A calicivirus isolated from a dog with fatal diarrhea. Vet Rec 132:221-222.
  179. Mochizuki M, San Gabriel MC, Nakatani H, et al. 1993. Comparison of polymerase chain reaction with virus isolation and haemagglutination assays for the detection of canine parvoviruses in faecal specimens. Res Vet Sci 55:60-63.
  180. Mockett APA, Stahl M. 1995. Comparing how puppies with passive immunity respond to three canine parvovirus vaccines. Vet Med 90:430-438.
  181. Mohr AJ, Leiswitz AL, Jacobson LS, et al. 2003. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 17:791-798.
  182. Moon HS, Lee SA, Lee SG, et al. 2008. Comparison of the pathogenicity in three different Korean canine parvovirus 2 (CPV-2) isolates. Vet Microbiol 131:47-56.
  183. Nandi S, Chidri S, Kumar M, et al. 2010. Occurrence of canine parvovirus type 2c in the dogs with haemorrhagic enteritis India. Res Vet Sci 898:169-171.
  184. Nappert G, Dunphy E, Ruben D, et al. 2002. Determination of serum organic acids in puppies with naturally acquired parvoviral enteritis. Can J Vet Res 66:15-18.
  185. Naveh A, Waner T, Wodowski I, et al. 1995. A rapid self-contained immunoblot ELISA test kit for the evaluation of antibody to canine parvovirus in dogs. Proc Int Congr Vet Virol 3:218-221.
  186. Naylor MJ, Monckton RP, Lehrbach PR, et al. 2001. Canine coronavirus in Australian dogs. Aust Vet J 79:116-119.
  187. Naylor MJ, Walia CS, McOrist S, et al. 2002. Molecular characterization confirms the presence of a divergent strain of canine coronavirus (UWSMN-1) in Australia. J Clin Microbiol 40:3518-3522.
  188. Nelson CDS, Minkkinen E, Bergkvist M, et al. 2008. Detecting small changes and additional peptides in the canine parvovirus capsid structure. J Virol 82:10397-10407.
  189. Nicholas BL, Brennan FR, Martinez-Torrecuadrada JL, et al. 2002. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine 20:2727-2734.
  190. Nicholas BL, Brennan FR, Hamilton WD, et al. 2003. Effect of priming/booster immunization protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct. Vaccine 21:2441-2447.
  191. Ntafis V, Mari V, Danika S, et al. 2010. An outbreak of canine coronavirus in puppies in a Greek kennel. J Vet Diagn Invest 22:320-323.
  192. Ntafis V, Xylouri E, Kalli I, et al. 2010. Characterization of canine parvovirus 2 variants circulating in Greece. J Vet Diagn Invest 22:737-740.
  193. O’Brien SE. 1994. Serologic response of pups to the low-passage, modified-like canine parvovirus-2 component in a combination vaccine. J Am Vet Med Assoc 204:1207-1209.
  194. O’Brien SE, Roth JA, Hill BL. 1986. Response of pups to modified-live canine parvovirus component in a combination vaccine. J Am Vet Med Assoc 188:699-701.
  195. Ogilvie GK. 2000. Dolasetron. A new option for nausea and vomiting. J Am Anim Hosp Assoc 36:481-483.
  196. Ohshima T, Hisaka M, Kawakami K, et al. 2008. Chronological analysis of canine parvovirus type 2 isolates in Japan. J Vet Med Sci 70:769-775.
  197. Ohshima T, Mochizuki M. 2009. Evidence for recombination between feline panleukopenia virus and canine parvovirus type 2. J Vet Med Sci 71:403-408.
  198. Otto CM, Drobatz KJ, Soter G. 1997. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 11:65-70.
  199. Otto CM, Jackson CB, Rogell EJ, et al. 2001. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial. J Vet Intern Med 15:355-360.
  200. Otto CM, Rieser TM, Brooks MB, et al. 2000. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 217:1500-1504.
  201. Pakkanen K, Nykky J, Vuento M. 2008. Late steps of parvoviral infection induce changes in cell morphology. Virus Res 137:271-274.
  202. Panda D, Patra RC, Nandi S, et al. 2009. Oxidative stress indices in gastroenteritis in dogs with canine parvoviral infection. Res Vet Sci 86: 36-42.
  203. Pardo C, Mackowiak M. 1995. Efficacy of a new canine origin, modified live virus vaccine against canine coronavirus. Rhone Merieux, Athens, GA.
  204. Pardo MC, Mackowiak M. 1999. Efficacy of a new canine origin, modified live virus vaccine against canine coronavirus. Canine Pract 24:6-8.
  205. Pardo MC, Mackowiak M. 2000. Safety of a new modified live virus vaccine against canine coronavirus. Canine Pract 25:16-19.
  206. Park JS, Choi BK, Vijayachandran LS, et al. 2007. Immunodetection of canine parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Escherichia coli as an antigen. J Virol Methods 146:281-287.
  207. Parrish CR. 1990. Emergence, natural history, and variation of canine, mink, and feline parvovirus. Adv Vir Res 38:403-450.
  208. Parrish CR. 1997. How canine parvovirus suddenly shifted host range. ASM News 63:307-311.
  209. Parrish CR. 1999. Host range relationships and the evolution of canine parvovirus. Vet Microbiol 69:29-40.
  210. Parrish CR, Aquadro CF, Strassheim ML, et al. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol 65:6544-6552.
  211. Patial S, Chaturvedi VK, Raia A, et al. 2007. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Vaccine 25:4020-4028.
  212. Pereira CAD, Leal ES, Durigon EL. 2007. Selective regimen shift and demographic growth increase associated with the emergence of high-fitness variants of canine parvovirus. Infect Genet Evol 7:399-409.
  213. Pérez R, Francia L, Romero V, et al. 2007. First detection of canine parvovirus type 2c in South America. Vet Microbiol 124:147-152.
  214. Phillips TR. 1989. Interactions of canine parvovirus with the immune system of the dog. Doctoral dissertation. University of Wisconsin—Madison.
  215. Phillips TR, Schultz RD. 1988. Failure of vaccine or virulent strains of canine parvovirus to induce immunosuppressive effects on the immune system of the dog. Viral Immunol 1:35-143.
  216. Phromnoi S, Sirinarumitr K, Sirinarumitr T. 2010. Sequence analysis of VP2 gene of canine parvovirus isolates in Thailand. Virus Genes 41:23-29.
  217. Pollock RVH, Carmichael LE. 1982. Maternally derived immunity to canine parvovirus infection: transfer, decline and interference with vaccination. J Am Vet Med Assoc 180:37-42.
  218. Pollock RVH, Carmichael LE. 1990. Canine viral enteritis, pp 268-287. In Greene CE (ed): Infectious diseases of the dog and cat. WB Saunders, Philadelphia.
  219. Pratelli A. 2006. Genetic evolution of canine coronavirus and recent advances in prophylaxis. Vet Res 37:191-200.
  220. Pratelli A. 2008. Canine coronavirus inactivation with physical and chemical agents. Vet J 117:1-79.
  221. Pratelli A. 2008. High-cell-passage canine coronavirus vaccine providing sterilizing immunity. J Small Anim Pract 48:574-578.
  222. Pratelli A, Altamura M, Buonavaglia D, et al. 2000. Evaluation of the natural immunity in pups inoculated with a modified-live canine parvovirus type 2b (CPV-2b) strain. Immunopharm Immunotox 22:451-464.
  223. Pratelli A, Buonavoglia D, Martella V, et al. 2000. Diagnosis of canine coronavirus infection using nested-PCR. J Virol Methods 84:91-94.
  224. Pratelli A, Buonavoglia D, Tepesta M, et al. 1999. Fatal canine parvovirus type-1 infection in pups from Italy. J Vet Diagn Invest 11:365-367.
  225. Pratelli A, Cavalli A, Normanno G, et al. 2000. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). J Vet Med B 47:273-276.
  226. Pratelli A, Cavalli A, Martella V, et al. 2001. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol 8:612-615.
  227. Pratelli A, Decaro M, Tinelli A, et al. 2004. Two genotypes of canine coronavirus simultaneously detected in the fecal samples of dogs with diarrhea. J Clin Microbiol 42:1797-1799.
  228. Pratelli A, Elia G, Martella V, et al. 2002. M gene evolution of canine coronavirus in naturally infected dogs. Vet Rec 151:758-761.
  229. Pratelli A, Elia G, Martella V, et al. 2001. Prevalence of variation of the sequence in the gene encoding for transmembrane protein M of canine coronavirus (CCV). Mol Cell Probes 15:229-233.
  230. Pratelli A, Elia G, Martella V, et al. 2002. Prevalence of canine coronavirus antibodies in dogs in the south of Italy by enzyme-linked immunosorbent assay. J Virol Methods 102:67-71.
  231. Pratelli A, Greco G, Camero M, et al. 2000. Isolation and identification of a calicivirus from a dog with diarrhoea. New Microbiol 23:257-260.
  232. Pratelli A, Martella V, Elia G, et al. 2000. Characterization of a calicivirus strain isolated from a pup with enteritis, pp. 196-197. In: Brocchi E, Lavazza A (eds.): Proceedings Fifth International Congress of ESVV. European Society for Veterinary Virology, Brescia Italy.
  233. Pratelli A, Martella V, Elia G, et al. 2001. Severe enteric disease in an animal shelter associated with dual infections by canine adenovirus type 1 and canine coronavirus. J Vet Med B 48:385-392.
  234. Pratelli A, Tempesta M, Greco G, et al. 1999. Development of a nested PCR assay for the detection of canine coronavirus. J Virol Methods 80:11-15.
  235. Pratelli A, Tempesta M, Roperto FP, et al. 1999. Fatal coronavirus infection in puppies following canine parvovirus 2b infection. J Vet Diagn Invest 11:550-553.
  236. Pratelli A, Tinelli A, Decaro N, et al. 2003. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol 26:151-155.
  237. Pratelli A, Tinelli A, Decaro N, et al. 2004. Safety and efficacy of a modified-live canine coronavirus vaccine in dogs. Vet Microbiol 99:43-49.
  238. Rewerts JM, Cohn LA. 2000. CVT update: diagnosis and treatment for parvovirus. In Bonagura JD (ed): Current veterinary therapy XIII. WB Saunders, Philadelphia.
  239. Rewerts JM, Harrington DP, McCaw D, et al. 1996. Effect of rhG-CSF administration on the clinical outcome of neutropenic parvovirus-infected puppies. J Vet Intern Med 10:178.
  240. Rewerts JM, McCaw DL, Cohn LA, et al. 1998. Recombinant human granulocyte colony stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 213:991-992.
  241. Rimmelzwann GF, Groen J, Egberink H, et al. 1991. The use of enzyme-linked immunosorbent assay system for serology and antigen detection in parvovirus, coronavirus, and rotavirus infections in dogs in The Netherlands. Vet Microbiol 26:25-40.
  242. Rimmelzwann GF, Juntti N, Klingeborn B, et al. 1990. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections. Vet Q 12:14-20.
  243. Roerink F, Hashimoto M, Tohya Y, et al. 1999. Organization of the canine calicivirus genome from the RNA polymerase gene to the poly (A) tail. J Gen Virol 80:929-935.
  244. Sahlström L, Bagge E, Emmoth E, et al. 2008. A laboratory study of survival of selected microorganisms after heat treatment of biowaste used in biogas plants. Bioresource Technol 99:7859-7865.
  245. Sanchez-Morgado JM, Poynter S, Morris TH. 2004. Molecular characterization of a virulent canine coronavirus BGF strain. Virus Res 104:27-31.
  246. 239a. Savigny MR, Macintire DK. 2010. Use of oseltamivir in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care 20:132-142.
  247. Schaffer FL, Soergel ME, Black JW, et al. 1985. Characterization of a new calicivirus isolated from feces of a dog. Arch Virol 84:181-195.
  248. Schatzberg SJ, Haley NJ, Barr SC, et al. 2003. Polymerase chain reaction (PCR) amplification of parvoviral DNA from the brains of dogs and cats with cerebellar hypoplasia. J Vet Intern Med 17:538-544.
  249. 241a. Schaudien D, Polizopoulou Z, Koutinas A, et al. 2010. Leukoencephalopathy associated with parvovirus infection in Cretan hound puppies. J Clin Microbiol 48:3169-3175.
  250. Schmitz S, Coenen C, Koenig M, et al. 2009. Comparison of three rapid commercial canine parvovirus antigen detection tests with electron microscopy and polymerase chain reaction. J Vet Diagn Invest 21:344-345.
  251. Schoeman JP, Goddard A, Herrtage ME. 2007. Serum cortisol and thyroxine concentrations as predictors of death in critically ill puppies with parvoviral diarrhea. J Am Vet Med Assoc 231:1534-1539.
  252. Schultz RD. 2006. Duration of immunity for canine and feline vaccines: a review. Vet Microbiol 117:75-79.
  253. 244a. Schultz RD. 2010. Personal communication, University of Wisconsin, Madison, WI.
  254. Schultz, RD, Larson LJ. 1996. The new generation of parvovirus vaccines. A comparison study. Compend Cont Educ Pract Vet 18:640-641.
  255. Schultz RD, Larson LJ, McCoy KP, et al. 1995. An evaluation of canine vaccines for their ability to provide protective immunity against challenge with canine parvovirus, pp 19-24. In Proceedings of the North American Veterinary Conference Orlando, Florida. Veterinary Learning Systems, Trenton, NJ.
  256. Schulz BS, Strauch C, Mueller RS, et al. 2008. Comparison of the prevalence of enteric viruses in healthy dogs and those with acute haemorrhagic diarrhoea by electron microscopy. J Small Anim Pract 49:84-88.
  257. Schwab S, Herden C, Seeliger F, et al. 2007. Non-suppurative meningoencephalitis of unknown origin in cats and dogs: an immunohistochemical study. J Comp Pathol 136: 96-110.
  258. Schwartz D, Green B, Carmichael LE, et al. 2002. The canine minute virus (minute virus of canines) is a distinct parvovirus that is most similar to bovine parvovirus. Virology 302:219-223.
  259. Senda M, Parrish CR, Harasawa R, et al. 1995. Detection by PCR of wild-type canine parvovirus which contaminates dog vaccines. J Clin Microbiol 33:110-113.
  260. Shackelton LA, Parrish CR, Truyen U, et al. 2005. High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc Natl Acad Sci USA 102:379-384.
  261. Siedek EM, Schmidt H, Munyira P, et al. 2007. Vanguard 7 protects against challenge with virulent canine parvovirus antigenic type 2c (CPV 2c), abstract P 06. Proceedings of the International Parvovirus Meeting, Sept 27-28, Bari, Italy.
  262. Siwicki AK, Krzyzanowski J, Bartoszcze M, et al. 1998. Adjuvant properties 253. of killed Propionibacterium avidum KP-40 in vaccination of dogs against canine parvovirus. DTW Dtsch Tierarztl Wochenschr 105:186-190.
  263. Sketchley P. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:428.
  264. Smith-Carr S, Macintire DK, Swango LJ. 1997. Canine parvovirus: part 1. Pathogenesis and vaccination. Compend Cont Educ Pract Vet 19:125-133.
  265. Sokolow SH, Rand C, Marks SL, et al. 2005. Epidemiologic evaluation of diarrhea in dogs in an animal shelter. Am J Vet Res 66:1018-1024.
  266. Soma T, Hara M, Ishii H, et al. 2001. Antibody testing against canine coronavirus by immunoperoxidase plaque staining. Vet Res Commun 25:327-336.
  267. Spibey N, Greenwood NM, Sutton D, et al. 2008. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet Microbiol 128:48-55.
  268. Stavisky J, Pinchbeck GL, German AJ, et al. 2010. Prevalence of canine enteric coronavirus in a cross-sectional survey of dogs presenting at veterinary practices. Vet Microbiol 140:18-24.
  269. Steinel A, Venter EH, Van Vuuren M, et al. 1998. Antigenic and genetic analysis of canine parvoviruses in southern Africa. Onderstepoort J Vet Res 65:239-242.
  270. Stern A. 2010. Vet med today: pathology in practice. J Am Vet Med Assoc 236:45-47.
  271. Sun Y, Chen AY, Cheng F, et al. 2009. Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol 83:3956-3967.
  272. Tennant BJ, Gaskell RM, Gaskell CJ. 1994. Studies on the survival of canine coronavirus under different environmental conditions. Vet Microbiol 42:255-259.
  273. Tennant BJ, Gaskell RM, Jones RC, et al. 1993. Studies on the epizootiology of canine coronavirus. Vet Rec 132:7-11.
  274. Tennant BJ, Gaskell RM, Kelly DF, et al. 1991. Canine coronavirus infection in the dog following oronasal inoculation. Res Vet Sci 51:11-18.
  275. Terpstra FG, van den Blink AE, Bos LM, et al. 2007. Resistance of surface-dried virus to common disinfection procedures. J Hosp Infect 66:332-338.
  276. Thiry E. 2010. Personal communication. University of Liege, Liege, Belgium.
  277. Thompson H. 2006. Efficacy of vaccination against canine parvovirus. Vet Rec 159:571.
  278. Touihri L, Bouzid I, Daoud R, Desario C, et al. 2009. First characterization of canine parvovirus strains circulating in dogs in Tunisia. Virus Genes 38:249-258.
  279. Traill P. 2006. Efficacy of canine parvovirus vaccination. Vet Rec 159: 688.
  280. Truyen U. 1999. Emergence and recent evolution of canine parvovirus. Vet Microbiol 69:47-50.
  281. Truyen U. 2006. Evolution of canine parvovirus—a need for new vaccines? Vet Microbiol 117:9-13.
  282. Truyen U, Evermann JF, Vieler E, et al. 1996. Evolution of canine parvovirus involved loss and gain of feline host range. Virology 215:186-189.
  283. Truyen U, Parrish CR. 1992. Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J Virol 66:5399-5408.
  284. Tsugawa T, Hoshino Y. 2008. Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans. Virology 380:344-353.
  285. Turk J, Fales, W, Miller M, et al. 1992. Enteric Clostridium perfringens infection associated with canine parvoviral enteritis: 74 cases (1987-1990). J Am Vet Med Assoc 200:991-994.
  286. Turk J, Miller M, Brown, T, et al. 1990. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988). J Am Vet Med Assoc 196:771-773.
  287. Uchida E, Ichijo S, Goto H, et al. 1988. Clinical, hematological and pathological findings in specific pathogen-free cats and conventional cats experimentally infected with canine parvovirus. Jpn J Vet Sci 50:597-604.
  288. Url A, Schmidt P. 2005. Do canine parvoviruses affect canine neurons? An immunohistochemical study. Res Vet Sci 79:57-59.
  289. Url A, Truyen U, Rebel-Bauder B, et al. 2003. Evidence of parvovirus replication in cerebral neurons of cats. J Clin Microbiol 41:3801-3805.
  290. Uwatoko K, Sunairi M, Nakajima M, et al. 1995. Rapid method utilizing the polymerase chain reaction for detection of canine parvovirus in feces of diarrheic dogs. Vet Microbiol 43:315-323.
  291. Van Nguyen SV, Umeda, K, Yokoyama H, et al. 2006. Passive protection of dogs against clinical disease due to canine parvovirus-2 by specific antibody from chicken egg yolk. Can J Vet Res 70:62-64.
  292. Vieira MJ, Silva E, Desario C. 2008. Natural co-infection with 2 parvovirus variants in dog. Emerg Infect Dis 14:678-679.
  293. Vieira MJ, Silva E, Oliveira J, et al. 2008. Canine parvovirus 2c infection in central Portugal. J Vet Diagn Invest 20:488-491.
  294. Veir JK, Duffy AL, Dow SW, et al. 2009. Comparison of quantitative PCR and conventional endpoint PCR for amplification of parvovirus DNA in blood from naturally infected and recently vaccinated dogs. J Vet Intern Med 23:673-786.
  295. Vlemmas I, Wohlsein P, Trautwein G, et al. 1990. Experimental parvovirus infection of puppies. Immunohistochemical findings. Berl Munch Tierarztl Wochenschr 103:422-425.
  296. Waldvogel AS, Hassam S, Stoerckle N, et al. 1992. Specific diagnosis of parvovirus enteritis in dogs and cats by in situ hybridization. J Comp Pathol 107:141-146.
  297. Waldvogel AS, Hassam S, Weilenmann R, et al. 1991. Retrospective study of myocardial canine parvovirus infection by in situ hybridization. Zentralbl Veterinarmed B 38:353-357.
  298. Waner T, Mazar S, Keren-Kornblatt E. 2006. Application of a dot enzyme-linked immunosorbent assay for evaluation of the immune status to canine parvovirus and distemper virus in adult dogs before revaccination. J Vet Diagn Invest 18:267-270.
  299. Waner T, Mazar S, Nachmias E, et al. 2003. Evaluation of a dot ELISA kit for measuring immunoglobulin M antibodies to canine parvovirus and distemper virus. Vet Rec 152:588-591.
  300. Waner T, Naveh A, Wodovsky I, et al. 1996. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. J Vet Diagn Invest 8:427-432.
  301. Wang HC, Chen WD, Lin SL, et al. 2005. Phylogenetic analysis of canine parvovirus VP2 gene in Taiwan. Virus Genes 31:171-174.
  302. Wang Y, Ma G, Lu C, et al. 2006. Detection of canine coronaviruses genotype I and II in raised Canidae animals in China. Berl Munch Tierarztl Wochenschr 119:35-39.
  303. Weissenbock H, Burtscher H. 1991. Fluorescence serologic and histologic studies of antigen distribution in parvovirus infections in dogs and cats. Zentralbl Veterinarmed B 38:481-491.
  304. Nho WG, Sur JH, Doster AR, Kim SB. 1997. Detection of canine parvovirus in naturally infected dogs with enteritis and myocarditis by in situ hybridization. J Vet Diagn Invest 9:255-260.
  305. Xylouri-Fragkiadaki, E. 2010. Personal communication. Faculty of Animal Science, Agricultural University, Athens, Greece.
  306. Yesilbağ K, Yilmaz Z, Özkul A, et al. 2007. Aetiological role of viruses in puppies with diarrhea. Vet Rec 161:169-170.
  307. Yi L, Cheng SP, Yan XJ, et al. 2009. Genetic variation analysis of canine parvovirus VP2 gene in China. Bing Du Xue Bao 25:452-459.
  308. Yilmaz Z, Senturk S. 2007. Characterisation of lipid profiles in dogs with parvoviral enteritis. J Small Anim Pract 48:643-650.
  309. Yoon SH, Jeong W, Kim HJ, et al. 2009. Molecular insights into the phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates: a Bayesian approach. Arch Virol 154:1353-1360.
  310. Yule TD, Roth MB, Dreier K, et al. 1997. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine 15:720-729.
  311. Zappulli V, Caliari D, Cavicchioli L, et al. 2008. Systemic fatal type II coronavirus infection in a dog: pathological findings and immunohistochemistry. Res Vet Sci 84:278-282.
  312. Zhang R, Yang S, Zhang W, et al. 2010. Phylogenetic analysis of the VP2 gene of canine parvoviruses circulating in China. Virus Genes, 40:397-402
  313. Zicola A, Mathjis E, Jolly S, et al. 2009. Emergence d’un coronavirus canin hautement pathogène: le coronavirus pantropique. http://www2:fmv.ulg.ac.be/divers/emergence_CCOV_ssfieldcode.pdf. Accessed 5/10/11.